<DOC>
	<DOCNO>NCT01405027</DOCNO>
	<brief_summary>The purpose study evaluate impact physician direct education program treatment compliance hepatitis C patient administered triple drug therapy pegylated interferon , ribavirin boceprevir .</brief_summary>
	<brief_title>Impact Physician Directed Education Patient Compliance With Hepatitis C Therapy</brief_title>
	<detailed_description>The new treatment paradigm HCV era protease inhibitor add level complexity previously see pegylated interferon ribavirin . In addition new concept utilization lead-in period , compliance TID dose regimen third agent , development resistance , futility rule decision point yet assess real life practice set . The OPTIMAL trial design evaluate impact education program community sit participate CLDF study treat chronic HCV genotype 1 patient . Group A comprise approximately 30 CLDF designate Hepatology Centers Educational Expertise ( HCEE ) Group B comprise approximately 60 community site . Group A also deliver educational program regarding use HCV protease inhibitor , overall treatment HCV approximately two ( 2 ) community sit 's geographic region . Group B comprise community site previous clinical trial experience boceprevir HCV protease inhibitor . For purpose study , community site Group B assign HCEE .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<criteria>Chronic Hepatitis C ( HCV ) genotype 1 Detectable HCVRNA within 180 day screen Age â‰¥ 18 year Weight &gt; 40 kg Patient partner ( ) must agree use acceptable method contraception Written inform consent Known coinfection HIV HBV Previous interferon ribavirin regimen require discontinuation adverse event consider related ribavirin and/or interferon Currently take plan take prohibited medication Evidence decompensated liver disease include presence clinical ascites , bleed varix , hepatic encephalopathy Diabetes and/or hypertension clinically significant ocular examination finding Preexisting psychiatric condition ( ) History severe uncontrolled psychiatric disorder Active alcohol drug abuse ( include marijuana ) Preexisting medical condition could interfere patient 's participation study Chronic obstructive pulmonary disease Abnormal lab value</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>HCV</keyword>
	<keyword>Genotype1</keyword>
	<keyword>Naive</keyword>
	<keyword>Partial responder</keyword>
	<keyword>Relapser</keyword>
</DOC>